Immediate Impact
8 standout
Citing Papers
Anti-Angiogenic Therapy: Current Challenges and Future Perspectives
2021 Standout
Anti-angiogenic agents — overcoming tumour endothelial cell anergy and improving immunotherapy outcomes
2021 Standout
Works of Elvira Schmidt being referenced
Cabozantinib Versus Standard-of-Care Comparators in the Treatment of Advanced/Metastatic Renal Cell Carcinoma in Treatment-naïve Patients: a Systematic Review and Network Meta-Analysis
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Elvira Schmidt | 101 | 39 | 10 | 21 | 12 | 166 | |
| Elizabeth Smyth | 82 | 65 | 11 | 22 | 17 | 175 | |
| Dat Tran | 156 | 28 | 12 | 11 | 10 | 212 | |
| Laura Battisti | 43 | 17 | 24 | 28 | 16 | 147 | |
| Stacey Rose | 94 | 69 | 6 | 13 | 14 | 221 | |
| Lene Fogt Lundbo | 79 | 48 | 11 | 27 | 20 | 179 | |
| Eric J. Mao | 167 | 43 | 7 | 10 | 15 | 277 | |
| Nathalie Chavarot | 75 | 94 | 12 | 13 | 17 | 231 | |
| Angela Dobes | 57 | 12 | 4 | 14 | 15 | 170 | |
| Jessica Rosenblum | 44 | 24 | 4 | 34 | 12 | 187 | |
| Threnesan Naidoo | 53 | 78 | 15 | 17 | 15 | 256 |
All Works
Login with ORCID to disown or claim papers
Loading papers...